Mass spectrometry innovations in drug discovery and development (original) (raw)

Recent advances in mass spectrometry for drug discovery and development

Nelson Cooke

2003

View PDFchevron_right

Mass spectrometry as a tool for biopharmaceutical drug development

rudjer novak

2018

View PDFchevron_right

Transformations in pharmaceutical research and development, driven by innovations in multidimensional mass spectrometry-based technologies

Roy Dobson

International Journal of Mass Spectrometry, 2001

View PDFchevron_right

A review on benefits of mass spectrometry for the small molecule drug discovery

hafiz akbar

2021

View PDFchevron_right

Mass Spectrometry Based Proteomics in Cancer Research

William Cho

Modern Molecular Biology, 2010

View PDFchevron_right

Mass spectrometry in high throughput analysis

Michael Greig

Spectroscopy, 2003

View PDFchevron_right

Evolving Role of Mass Spectrometry in Drug Discovery and Development

Dil Ramanathan

Ramanathan/Drug Metabolism and Pharmacokinetics, 2008

View PDFchevron_right

Mass Spectrometry in Drug Discovery

Charles Wilkins

TrAC Trends in Analytical Chemistry, 2002

View PDFchevron_right

The Role of Mass Spectrometry in the “Omics” Era

Maurizio Muraca, Isabella Lante, Lorenza Putignani

Current Organic Chemistry, 2013

View PDFchevron_right

The Relevance of Mass Spectrometry Analysis for Personalized Medicine through Its Successful Application in Cancer “Omics”

Ovidiu Coza

International Journal of Molecular Sciences

View PDFchevron_right

Part 1. High-Throughput Mass Spectrometry for Biopharma: A Universal Modality and Target Independent Analytical Method for Accurate Biomolecule Characterization

Pascal F . Egea

High-Throughput Mass Spectrometry for Biopharma: A Universal Modality and Target Independent Analytical Method for Accurate Biomolecule Characterization, 2022

View PDFchevron_right

Biological issues prove the primary motivations Report on the Sixth International Symposium on Mass Spectrometry in the Health and Life Sciences: Molecular and Cellular Proteomics, San Francisco, California, USA, 24–28 August 2003

Charles Wilkins

TrAC Trends in Analytical Chemistry

View PDFchevron_right

Advances and challenges in analytical characterization of biotechnology products: Mass spectrometry-based approaches to study properties and behavior of protein therapeutics

Guanbo Wang

Biotechnology Advances, 2012

View PDFchevron_right

Open-access high-resolution mass spectrometry in early drug discovery

Ute Gerhard

Journal of Mass Spectrometry, 2004

View PDFchevron_right

Intact Protein Mass Spectrometry for Therapeutic Protein Quantitation, Pharmacokinetics, and Biotransformation in Preclinical and Clinical Studies: An Industry Perspective

Jack Henion

Journal of the American Society for Mass Spectrometry, 2020

View PDFchevron_right

Characterization of protein therapeutics by mass spectrometry: recent developments and future directions

Adrienne Tymiak

Drug Discovery Today, 2011

View PDFchevron_right

Enhanced mass resolution method development, validation and assay application to support preclinical studies of a new drug candidate

Edith Monteagudo

Rapid Communications in Mass Spectrometry, 2006

View PDFchevron_right

Analytical validation of accelerator mass spectrometry for pharmaceutical development

Bradly Keck

Bioanalysis, 2010

View PDFchevron_right

Emerging mass spectrometry-based proteomics methodologies for novel biomedical applications

Samah Shah

Biochemical Society Transactions

View PDFchevron_right

Quantitative Clinical Chemistry Proteomics (qCCP) using mass spectrometry: general characteristics and application

Christophe Hirtz, Matthias Glueckmann, José Cocho, Jérôme Vialaret

Clinical Chemistry and Laboratory Medicine, 2000

View PDFchevron_right

Mass spectrometry — One of the pillars of proteomics

Martina Marchetti-Deschmann

Journal of Proteomics, 2011

View PDFchevron_right

Methods Development in Biological Mass Spectrometry: Applications in Small Molecule Research and Proteomics

Taufika Williams

2005

View PDFchevron_right

Using mass spectrometry for drug metabolism studies

Ragu Ramanathan, W. Korfmacher

Journal of the American Society for Mass Spectrometry, 2006

View PDFchevron_right

Comparative evaluation of mass spectrometry platforms used in large-scale proteomics investigations

Joshua Elias

Nature Methods, 2005

View PDFchevron_right

15th Nordic Conference in Mass Spectrometry

Dag Ekeberg

View PDFchevron_right

Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Pharmacy 234 Development and Application of Software Tools for Mass Spectrometry Imaging

Patrik Källback

2017

View PDFchevron_right

Future technology insight: mass spectrometry imaging as a tool in drug research and development

Per Andrén

British journal of pharmacology, 2015

View PDFchevron_right

The emerging process of Top Down mass spectrometry for protein analysis: biomarkers, protein-therapeutics, and achieving high throughput

Dorothy Ahlf Wheatcraft

Molecular …, 2010

View PDFchevron_right

Recent advances in the clinical application of mass spectrometry

Ronda Greaves

View PDFchevron_right

Mass spectrometry-based clinical proteomics

Visnja Bacun-Druzina

Pharmacogenomics, 2003

View PDFchevron_right

TARGETED MASS spectrometry Imaging: Specific Targeting Mass Spectrometry imaging technologies from history to perspective

Isabelle Fournier

Progress in Histochemistry and Cytochemistry, 2012

View PDFchevron_right

Preprocessing, management, and analysis of mass spectrometry proteomics data

Tommaso Mazza

2005

View PDFchevron_right

Demonstration of Direct Bioanalysis of Drugs in Plasma Using Nanoelectrospray Infusion from a Silicon Chip Coupled with Tandem Mass Spectrometry

Jack Henion

Analytical Chemistry, 2003

View PDFchevron_right